ScienceBits

What Is Piperine? Bioavailability, Drug Interactions, Safety and What Research Shows

May 15, 2025
What Is Piperine? Bioavailability, Drug Interactions, Safety and What Research Shows

Piperine is the compound best known for giving black pepper its characteristic pungent taste. In dietary supplements, concentrated black pepper extracts are also commonly included because piperine can influence the absorption, metabolism, and transport of certain compounds.

That is why piperine is often described as a “bioavailability enhancer.” But this description needs context.

Changing bioavailability is not automatically beneficial. The same mechanisms that may increase exposure to one supplement ingredient can also change how the body processes certain medications.

“Piperine can influence the pharmacokinetics of certain compounds, but ‘better absorption’ is not a universal benefit and should not be assumed for every nutrient, botanical, medication, or finished supplement.”

Quick Answer: What Is Piperine?

Piperine is a naturally occurring alkaloid found primarily in black pepper (Piper nigrum) and some related Piper species.

Research suggests that concentrated piperine can influence certain metabolic enzymes and transport proteins involved in how compounds are absorbed and eliminated.

Human studies show that these effects are compound-, dose-, and formulation-specific. Piperine should not be described as a universal absorption enhancer, and concentrated piperine supplements deserve additional caution when medications are being used.

Is Piperine the Same as Black Pepper?

No.

Black pepper is a whole spice containing piperine together with many other naturally occurring plant compounds.

A concentrated black pepper extract used in a dietary supplement may be standardized to contain a much higher proportion of piperine.

That distinction matters because eating black pepper as part of a meal is not necessarily equivalent to swallowing a concentrated piperine-rich extract in a capsule.

The amount, concentration, timing, food context, and pattern of exposure can all differ.

What Does Bioavailability Mean?

In pharmacokinetics, bioavailability generally refers to the rate and extent to which an administered compound reaches systemic circulation.

This is different from simply asking how many milligrams appear on a label.

Exposure to a compound can be affected by:

  • How well it dissolves
  • How efficiently it crosses the intestinal barrier
  • Transport proteins in the intestine
  • Metabolism in the intestinal wall
  • First-pass metabolism in the liver
  • The chemical form of the compound
  • Food and other ingredients taken at the same time
  • Individual physiology

For that reason, two products containing the same milligram amount do not necessarily produce the same blood concentrations or pharmacokinetic profile.

How Can Piperine Affect Bioavailability?

Piperine has been studied for its ability to influence several biological processes involved in drug and compound disposition.

Experimental research has investigated effects involving:

  • Cytochrome P450 enzymes, including CYP3A4
  • P-glycoprotein and other transport processes
  • Intestinal metabolism
  • Glucuronidation pathways
  • Intestinal permeability and membrane dynamics

These mechanisms help explain why researchers have tested piperine alongside compounds that normally have low systemic exposure.

However, much of the detailed mechanistic evidence comes from laboratory, animal, or pharmacokinetic research.

Mechanism Is Not the Same as a Clinical Benefit

Mechanistic evidence: Piperine changes an enzyme, transporter, or metabolic pathway.

Pharmacokinetic evidence: Co-administration changes blood concentration, Cmax, AUC, half-life, or another exposure measurement.

Clinical outcome evidence: The change produces a meaningful health benefit in people without creating unacceptable risks.

These are three different questions.

Does Piperine Increase Curcumin Bioavailability by 2,000%?

This widely repeated number comes from a specific human pharmacokinetic study published in 1998.

Eight healthy volunteers received 2 grams of curcumin, either alone or together with 20 mg of piperine.

In that experimental setting, adding piperine produced substantially higher measured curcumin exposure, reported by the investigators as a 2,000% increase in bioavailability.

The finding is important historically, but it should not be interpreted as:

  • Piperine increases every nutrient by 2,000%
  • Any dose of piperine produces the same effect
  • 5 mg and 20 mg of piperine are clinically interchangeable
  • Every form of curcumin behaves the same way
  • The same effect occurs with ashwagandha, maca, vitamins, or minerals
  • Greater blood exposure automatically produces a better health outcome

The study tested a specific combination, in a small number of people, under a specific pharmacokinetic protocol.

Why the Famous “2,000%” Number Needs Context

Curcumin: 2,000 mg

Piperine: 20 mg

Human participants: 8

Outcome: Pharmacokinetic exposure to curcumin—not proof that piperine improves every supplement ingredient or guarantees a better clinical outcome.

Does Piperine Improve the Absorption of Every Supplement?

No.

The effect of piperine depends on the specific compound and the mechanisms involved in its absorption and metabolism.

A vitamin, mineral, botanical extract, pharmaceutical drug, and fat-soluble compound can have very different pharmacokinetic characteristics.

It is therefore not scientifically appropriate to say that adding black pepper extract automatically:

  • Makes every ingredient more absorbable
  • Allows the body to use every milligram
  • Makes a formula more effective
  • Compensates for a lower dose of another ingredient
  • Guarantees ingredient synergy

Evidence should be specific to the ingredient combination, amounts, formulation, and outcome being discussed.

Why Can Piperine Interact With Medications?

The mechanisms that make piperine interesting for bioavailability research also create an important safety question.

Drug-metabolizing enzymes and transport proteins help control how quickly many medications enter and leave the bloodstream.

If piperine changes those pathways, exposure to a medication may also change.

Human pharmacokinetic studies have reported changes when piperine was administered with medications including:

  • Phenytoin
  • Propranolol
  • Theophylline
  • Nevirapine
  • Other drugs evaluated in pharmacokinetic interaction research

A 2023 systematic review and meta-analysis of clinical studies found increases in several pharmacokinetic measures, including maximum blood concentration and area under the concentration-time curve, when certain CYP-metabolized drugs were administered with piperine.

This does not mean piperine interacts dangerously with every medication.

It means that concentrated piperine should not be treated as pharmacologically irrelevant simply because it comes from black pepper.

What About CYP3A4 and P-Glycoprotein?

CYP3A4 is one of the major enzymes involved in the metabolism of many medications.

P-glycoprotein is a transporter involved in moving certain compounds across cell membranes and can influence drug absorption and elimination.

Laboratory research has shown that piperine can inhibit CYP3A4 activity and P-glycoprotein-mediated transport under experimental conditions.

Human pharmacokinetic studies involving various medications provide additional evidence that piperine can alter systemic drug exposure.

A 2024 physiologically based pharmacokinetic modeling study also predicted potentially meaningful changes in exposure to several CYP3A4-substrate drugs after repeated piperine intake.

However, a computer pharmacokinetic model is not the same as observing an interaction directly in a clinical trial.

The practical conclusion is therefore not that everyone taking medication will experience an interaction, but that medication use deserves additional caution.

Using Medication? Review Concentrated Piperine With a Professional

If you regularly use prescription or clinically important medications, discuss concentrated black pepper extract or piperine supplements with a physician or pharmacist.

This is particularly important when medication exposure needs to remain within a narrow therapeutic range or when changes in blood concentration could have meaningful consequences.

Do not change a medication dose or dosing schedule based on a supplement article.

Is Piperine Safe to Take Every Day?

There is an important difference between culinary exposure to black pepper and repeated supplementation with highly concentrated piperine.

A 2021 safety review from researchers at the German Federal Institute for Risk Assessment concluded that available human studies are not sufficient for a complete assessment of the long-term safety of isolated piperine taken in concentrated bolus form.

The review noted that drug interactions are one of the clearest human safety concerns.

Human studies have generally been short and were often designed to investigate pharmacokinetics rather than long-term safety.

For that reason, it is more accurate to say that:

  • Culinary black pepper has a long history of food use
  • Concentrated piperine extracts create a different exposure pattern
  • Human long-term safety data for isolated supplemental piperine are limited
  • Medication interactions deserve particular attention

Who Should Be More Careful With Piperine Supplements?

Additional caution is reasonable if you:

  • Take prescription medications
  • Use a medication with a narrow therapeutic range
  • Take several medications or supplements at the same time
  • Are preparing for surgery or another medical procedure
  • Are pregnant, trying to become pregnant, or breastfeeding
  • Have a medical condition requiring stable medication concentrations
  • Have previously experienced significant reactions to concentrated botanical extracts

Human pregnancy and reproductive-safety data for concentrated piperine supplements are limited. Safety reviews have therefore recommended a conservative approach during pregnancy, particularly because concentrated supplemental exposure is different from normal culinary use of pepper.

How Much Black Pepper Extract Is in RevitaPlus Stress Calm?

RevitaPlus Stress Calm has a serving size of two capsules.

The current formula lists:

  • Black Pepper Extract standardized to 95% piperine — 5 mg

The formula also contains:

  • Ashwagandha Extract 10:1 — 500 mg
  • Maca Extract 10:1 — 300 mg
  • Magnesium from magnesium glycinate — 54 mg
  • Zinc from zinc glycinate — 15 mg
  • Vitamin B6 — 2 mg
  • Vitamin B12 — 500 mcg
  • Folate — 1,334 mcg DFE, including 800 mcg folic acid

Does 5 mg of Black Pepper Extract Prove Better Absorption of the Complete Formula?

No.

The label identifies 5 mg of black pepper extract standardized to 95% piperine.

That does not establish that the amount produces the same pharmacokinetic effect as a study using 20 mg of piperine, nor does it prove increased absorption of ashwagandha, maca, magnesium, B vitamins, zinc, or the complete Stress Calm formula.

The finished Stress Calm formula has not been established in a human pharmacokinetic study showing that its black pepper extract increases systemic exposure to the other ingredients.

For more information about two other botanicals in the same formula, read our guides to ashwagandha, stress, sleep and safety and maca, energy, mood, menopause and safety.

Black Pepper Extract Within a Structured Stress Calm Formula

RevitaPlus Stress Calm includes 5 mg of black pepper extract standardized to 95% piperine within a two-capsule daily serving.

The ingredient should be described according to the actual Supplement Facts panel—not as proof that the complete formula has enhanced absorption, guaranteed synergy, or greater clinical effectiveness.

If you take medication, review the complete formula with a healthcare professional or pharmacist before use.

Explore RevitaPlus Stress Calm

The Key Takeaway

Piperine is a naturally occurring component of black pepper with genuine pharmacokinetic activity.

Research shows that it can influence the exposure of certain compounds and medications.

The famous curcumin study demonstrates that piperine can substantially change the pharmacokinetics of a specific compound under a specific set of conditions.

But this evidence does not justify describing piperine as:

  • A universal nutrient-absorption enhancer
  • A guarantee of better supplement effectiveness
  • A way to make every ingredient “fully absorbed”
  • Proof of formula synergy
  • A reason to assume lower doses of other ingredients are equivalent to higher researched doses

The scientifically important question is not simply whether piperine can increase bioavailability.

It is: Which compound, at what piperine dose, in which formulation, under what conditions—and with what consequences?

That question applies equally to potential benefits and potential medication interactions.

Frequently Asked Questions About Piperine

What is piperine?

Piperine is a naturally occurring alkaloid found primarily in black pepper. It contributes to the spice’s pungent taste and has been studied for its effects on metabolic enzymes, transport proteins, and the pharmacokinetics of certain compounds.

Does piperine increase absorption?

Piperine can alter the bioavailability of certain compounds under specific conditions, but it is not a universal absorption enhancer. The effect depends on the compound, piperine amount, formulation, and metabolic pathways involved.

Does piperine increase curcumin absorption by 2,000%?

A small 1998 pharmacokinetic study in eight healthy volunteers reported a 2,000% increase in measured curcumin bioavailability when 20 mg of piperine was given with 2 g of curcumin. This result applies to that specific experimental combination and should not be generalized to every dose, ingredient, or supplement.

Does piperine increase the absorption of ashwagandha or maca?

The presence of piperine in the same formula does not by itself prove increased absorption of ashwagandha or maca. A formulation-specific pharmacokinetic study would be needed to establish the magnitude and clinical relevance of such an effect.

Can piperine interact with medications?

Yes, piperine has altered the pharmacokinetics of several medications in human studies. Because effects depend on the drug, dose, timing, and individual factors, people using medication should discuss concentrated piperine supplements with a physician or pharmacist.

Is black pepper in food the same as piperine in a supplement?

No. Culinary black pepper contains piperine together with many other pepper components and is typically eaten as part of food. Supplements may contain highly concentrated standardized extracts taken as a discrete dose, creating a different exposure pattern.

Is piperine safe to take every day?

Available human research does not provide a complete assessment of long-term daily use of concentrated isolated piperine. Drug interactions are an important consideration, particularly for people who regularly use medications.

How much black pepper extract is in RevitaPlus Stress Calm?

Each two-capsule serving lists 5 mg of black pepper extract standardized to 95% piperine. This amount has not been established as proof that the complete Stress Calm formula has enhanced absorption or a clinically proven bioavailability advantage.

Sources & Further Reading

  1. Shoba G, et al. “Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers.” Planta Medica. 1998;64(4):353–356.
  2. Bhardwaj RK, et al. “Piperine, a major constituent of black pepper, inhibits human P-glycoprotein and CYP3A4.” Journal of Pharmacology and Experimental Therapeutics. 2002;302(2):645–650.
  3. Lee SH, et al. “Piperine-mediated drug interactions and formulation strategy for piperine: recent advances and future perspectives.” Expert Opinion on Drug Metabolism & Toxicology. 2018;14(1):43–57.
  4. Ziegenhagen R, et al. “Safety Aspects of the Use of Isolated Piperine Ingested as a Bolus.” Foods. 2021;10(9):2121.
  5. Pradeepa BR, Vijayakumar TM, Manikandan K, Kammala AK. “Cytochrome P450-mediated alterations in clinical pharmacokinetic parameters of conventional drugs coadministered with piperine: a systematic review and meta-analysis.” Journal of Herbal Medicine. 2023;41:100713.
  6. Pattanaik S, et al. “Effect of piperine on the steady-state pharmacokinetics of phenytoin in patients with epilepsy.” Phytotherapy Research. 2006;20(8):683–686.
  7. Bano G, et al. “Effect of piperine on bioavailability and pharmacokinetics of propranolol and theophylline in healthy volunteers.” European Journal of Clinical Pharmacology. 1991;41(6):615–617.

This article is for general educational purposes and is not a substitute for medical advice, diagnosis, or treatment.